We are live on ! Find out more
NB

Norinchukin Bank Portfolio holdings

AUM $8.57B
1-Year Est. Return 20.17%
This Fund
S&P 500
This Quarter Est. Return
+8.76%
1 Year Est. Return
+20.17%
3 Year Est. Return
+71.71%
5 Year Est. Return
+89.7%
10 Year Est. Return
+317.21%
AUM
$7.66B
AUM Growth
+$575M
Cap. Flow
-$13.4M
Cap. Flow %
-0.17%
Top 10 Hldgs %
49.81%
Holding
518
New
9
Increased
34
Reduced
465
Closed
7

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$25.4M
2
V icon
Visa
V
+$22.9M
3
BDX icon
Becton Dickinson
BDX
+$21.5M
4
DIS icon
Walt Disney
DIS
+$18.9M
5
TXN icon
Texas Instruments
TXN
+$18.3M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$25.1M
2
TIF
Tiffany & Co.
TIF
+$17.4M
3
AAPL icon
Apple
AAPL
+$14.7M
4
CELG
Celgene Corp
CELG
+$12.4M
5
AMZN icon
Amazon
AMZN
+$8.74M

Sector Composition

Rank Sector Weight
1 Technology 14.19%
2 Healthcare 9.8%
3 Industrials 6.84%
4 Communication Services 6.72%
5 Consumer Discretionary 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DUK icon
101
Duke Energy
DUK
$97.3B
$10.8M 0.14%
117,891
-8,659
-7% -$794K
TGT icon
102
Target
TGT
$68B
$10.6M 0.14%
82,805
-7,019
-8% -$824K
C icon
103
Citigroup
C
$226B
$10.6M 0.14%
132,073
-32,030
-20% -$2.37M
WBA
104
DELISTED
Walgreens Boots Alliance
WBA
$10.4M 0.14%
176,000
-3,965
-2% -$229K
AGN
105
DELISTED
Allergan plc
AGN
$10.2M 0.13%
53,587
-3,924
-7% -$708K
ELV icon
106
Elevance Health
ELV
$85.5B
$10.1M 0.13%
33,574
-3,496
-9% -$962K
CI icon
107
Cigna
CI
$74.6B
$10.1M 0.13%
49,447
-5,137
-9% -$942K
RTN
108
DELISTED
Raytheon Company
RTN
$9.89M 0.13%
45,028
-3,374
-7% -$713K
TJX icon
109
TJX Companies
TJX
$178B
$9.8M 0.13%
160,574
-14,176
-8% -$838K
DOW icon
110
Dow Inc
DOW
$21.2B
$9.51M 0.12%
173,717
-2,735
-2% -$141K
TRV icon
111
Travelers Companies
TRV
$80.2B
$9.27M 0.12%
67,673
+3,148
+5% +$429K
INTU icon
112
Intuit
INTU
$89B
$9.23M 0.12%
35,252
-3,018
-8% -$789K
D icon
113
Dominion Energy
D
$59.3B
$9.12M 0.12%
110,108
-9,820
-8% -$802K
SLB icon
114
SLB Ltd
SLB
$75B
$9.11M 0.12%
226,511
-16,404
-7% -$586K
FISV
115
Fiserv Inc
FISV
$27.9B
$8.98M 0.12%
77,673
-6,748
-8% -$745K
SYK icon
116
Stryker
SYK
$130B
$8.95M 0.12%
42,634
-3,749
-8% -$778K
BIIB icon
117
Biogen
BIIB
$30.7B
$8.82M 0.12%
29,724
-2,848
-9% -$790K
BSX icon
118
Boston Scientific
BSX
$71.5B
$8.35M 0.11%
184,561
-16,757
-8% -$701K
MU icon
119
Micron Technology
MU
$991B
$8.06M 0.11%
149,941
-12,768
-8% -$610K
PLD icon
120
Prologis
PLD
$133B
$8.03M 0.1%
90,038
-6,945
-7% -$616K
SPG icon
121
Simon Property Group
SPG
$72.3B
$7.93M 0.1%
53,271
-3,668
-6% -$550K
CCI icon
122
Crown Castle
CCI
$32.2B
$7.82M 0.1%
55,041
-5,063
-8% -$691K
AMAT icon
123
Applied Materials
AMAT
$428B
$7.74M 0.1%
126,772
-11,314
-8% -$636K
DD icon
124
DuPont de Nemours
DD
$19.2B
$7.69M 0.1%
95,437
-7,745
-8% -$643K
CSX icon
125
CSX Corp
CSX
$93.1B
$7.62M 0.1%
316,011
-36,966
-10% -$874K

Similar funds

Norinchukin Bank's Q4 2019 Portfolio in Review

As of Q4 2019, Norinchukin Bank held 518 positions worth $7.66B, up 8.1% from $7.08B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.1%. Norinchukin Bank opened 9 new positions and exited 7, leaving the 518-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

  • Norinchukin Bank's largest Q4 2019 buy was ServiceNow: 124,865 shares worth $7.05M.
  • Norinchukin Bank added most to Colgate-Palmolive in Q4 2019, an estimated $25.4M increase.
  • Norinchukin Bank's biggest Q4 2019 reduction was Microsoft, cutting an estimated $25.1M.
  • Norinchukin Bank fully exited Celgene Corp in Q4 2019, selling an estimated $12.4M.
  • Norinchukin Bank's ten largest holdings make up 50% of its $7.66B portfolio in Q4 2019.
  • Norinchukin Bank opened 9 new positions and closed 7 in Q4 2019.
  • Norinchukin Bank's portfolio value rose 8.1% quarter-over-quarter to $7.66B.

Based on Norinchukin Bank's 13F filing for Q4 2019, filed 12 Feb 2020.